» Articles » PMID: 29540997

Overexpression of Rab11-FIP2 in Colorectal Cancer Cells Promotes Tumor Migration and Angiogenesis Through Increasing Secretion of PAI-1

Overview
Journal Cancer Cell Int
Publisher Biomed Central
Date 2018 Mar 16
PMID 29540997
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Rab11 family-interacting protein 2 (Rab11-FIP2) can interact with MYO5B and plays an important role in regulating plasma membrane recycling. However, little is known about the clinical significance of DUSP2 in colorectal cancer (CRC).

Methods: In this study, we investigated Rab11-FIP2 expression by immunohistochemistry in 125 patients with colorectal cancer. Conditioned media containing all secreted factors was harvested. Chemokine secretion and expression were analyzed by Chemi-array.

Results: We found that the expression level of Rab11-FIP2 was significantly increased in colorectal cancer tissues and high expression of Rab11-FIP2 was closely correlated with nodal metastasis in colorectal cancer patients. Rab11-FIP2 overexpression promoted colorectal cancer metastasis in vitro and in vivo. Finally, we demonstrated that Rab11-FIP2 overexpression may contribute to increased secretion of PAI-1 in human colorectal cancer cells.

Conclusions: Our findings reveal a novel mechanism underlying the role of Rab11-FIP2 in colorectal cancer dissemination, suggesting that targeting Rab11-FIP2 might be a promising therapeutic strategy for CRC.

Citing Articles

Proteomic study of medicinal mushroom extracts reveals antitumor mechanisms in an advanced colon cancer animal model via ribosomal biogenesis, translation, and metabolic pathways.

Jakopovic B, Horvatic A, Baranasic J, Car I, Orsolic N, Jakopovich I Front Pharmacol. 2024; 15:1475102.

PMID: 39494346 PMC: 11528127. DOI: 10.3389/fphar.2024.1475102.


Exploring Pathway to Hinder Chronic Myeloid Leukemia-Induced Angiogenesis In Vivo.

Roma-Rodrigues C, Fernandes A, Baptista P Pharmaceutics. 2023; 15(3).

PMID: 36986603 PMC: 10056245. DOI: 10.3390/pharmaceutics15030742.


Inducible miR-1224 silences cerebrovascular Serpine1 and restores blood flow to the stroke-affected site of the brain.

Palakurti R, Biswas N, Roy S, Gnyawali S, Sinha M, Singh K Mol Ther Nucleic Acids. 2023; 31:276-292.

PMID: 36726407 PMC: 9868883. DOI: 10.1016/j.omtn.2022.12.019.


MicroRNA-200c Attenuates the Tumor-Infiltrating Capacity of Macrophages.

Raue R, Frank A, Fuhrmann D, Cruz-Ojeda P, Rosser S, Bauer R Biology (Basel). 2022; 11(3).

PMID: 35336722 PMC: 8945044. DOI: 10.3390/biology11030349.


The dual functions of Rab11 and Rab35 GTPases-regulation of cell division and promotion of tumorigenicity.

Gibieza P, Petrikaite V Am J Cancer Res. 2021; 11(5):1861-1872.

PMID: 34094658 PMC: 8167671.


References
1.
Elzi D, Lai Y, Song M, Hakala K, Weintraub S, Shiio Y . Plasminogen activator inhibitor 1--insulin-like growth factor binding protein 3 cascade regulates stress-induced senescence. Proc Natl Acad Sci U S A. 2012; 109(30):12052-7. PMC: 3409757. DOI: 10.1073/pnas.1120437109. View

2.
Ducharme N, Jin M, Lapierre L, Goldenring J . Assessment of Rab11-FIP2 interacting proteins in vitro. Methods Enzymol. 2006; 403:706-15. DOI: 10.1016/S0076-6879(05)03061-2. View

3.
Soff G, Sanderowitz J, Gately S, Verrusio E, Weiss I, Brem S . Expression of plasminogen activator inhibitor type 1 by human prostate carcinoma cells inhibits primary tumor growth, tumor-associated angiogenesis, and metastasis to lung and liver in an athymic mouse model. J Clin Invest. 1995; 96(6):2593-600. PMC: 185963. DOI: 10.1172/JCI118323. View

4.
Schmitt J, Matei D . Targeting angiogenesis in ovarian cancer. Cancer Treat Rev. 2011; 38(4):272-83. DOI: 10.1016/j.ctrv.2011.06.004. View

5.
Jeon H, Kim J, Kim J, Lee W, Lee M, Suk K . Plasminogen activator inhibitor type 1 regulates microglial motility and phagocytic activity. J Neuroinflammation. 2012; 9:149. PMC: 3418576. DOI: 10.1186/1742-2094-9-149. View